Back

Effect of beta-blocker dose on the prognosis in chronic heart failure patients depending on the presence of atrial fibrillation. Data from FAR NHL (FARmacology and NeuroHumoraL activation) registry.

1 September 2019 (12:03 - 12:12)
Organised by:
Congress Presentation Part of: New treatment studies in heart failure Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Karel Labr

St. Anne University Hospital Brno (FNUSA), Brno (Czechia)

8 More presentations in this session

Presentation thumbnail
Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial
Doctor D. Fouassier (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction
Doctor J. Cheng (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial
Doctor H. Kihara (Asahikawa, JP)
Abstract Slides Video
Presentation thumbnail
Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis
Associate Professor A. Kalogeropoulos (Stony Brook, US)
Presentation thumbnail
Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
Mr M. Godet (Rouen, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New treatment studies in heart failure

The Event

Event poster

ESC Congress 2019

1 September 2019 12:03 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Webinar
MRAs in heart failure: what's old is new again

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources